— Know what they know.
Not Investment Advice

TFX NYSE

Teleflex Incorporated
1W: +6.0% 1M: +9.2% 3M: +3.3% YTD: +13.6% 1Y: +5.8% 3Y: -24.4% 5Y: -61.0%
$139.00
+2.20 (+1.61%)
 
Weekly Expected Move ±4.1%
$125 $131 $136 $142 $148
NYSE · Healthcare · Medical - Instruments & Supplies · Tech Score Strong Buy · Power 70 · $5.9B mcap · 42M float · 1.49% daily turnover · Short 72% of daily vol
Credit Risk of going bust: higher than 52% of companies Debt: 32.8% of company value Bonds: $146.4M held by 149 funds, 136 bp over Treasuries → details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $5.05 (down 96%), Teleflex Incorporated would be worth roughly what it owes.
Total debt $2.87B against a stock market value of $5.89B.
Distance to default 4.97 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $1.45B (short-term plus half of long-term), stock volatility 39.9%; Altman Z 1.99. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.

Supply Chain Overview

7 relationships
7
As Filer
counterparties named
0
As Counterparty
mentioned by others
2
Rel. Types
2025-02-27
Earliest Filing
2025-12-09
Latest Filing
acquirer: 6 target: 1

Counterparties (Filed by TFX)

7 relationships

Companies named in TFX's SEC 8-K filings as business counterparties.

Counterparty Ticker Relationship Summary Filing Date SEC
Lotus US Bidco Inc. — acquirer Acquired Teleflex's Original Equipment Manufacturing and Development Services business for $1.5 billion. 2025-12-09 View
Intersurgical Limited INTR acquirer Acquired Teleflex's Acute Care and Interventional Urology segments for $530 million. 2025-12-09 View
Intersurgical AG INTR acquirer Signatory to the Equity Purchase Agreement for the Acute Care and Urology transaction. 2025-12-09 View
Intersurgical Inc. INTR acquirer Signatory to the Equity Purchase Agreement for the Acute Care and Urology transaction. 2025-12-09 View
Engineered Medical Systems Inc. — acquirer Signatory to the Equity Purchase Agreement for the Acute Care and Urology transaction. 2025-12-09 View
Pulmodyne Inc. — acquirer Signatory to the Equity Purchase Agreement for the Acute Care and Urology transaction. 2025-12-09 View
BIOTRONIK SE & Co. KG — target Target of Teleflex's proposed acquisition of the Vascular Intervention business. 2025-02-27 View
Recent 8-K Filings (20)
Filing Date Description Type SEC
2026-09-09 Officer/Director Change; Regulation FD; Exhibits View
2026-08-07 Other Events View
2026-08-06 Earnings Release; Regulation FD; Exhibits View
2026-08-05 Exhibits View
2026-08-03 Acquisition/Disposition; Regulation FD; Exhibits Acquisition View
2026-06-15 Material Agreement; Financial Obligation; Exhibits Agreement View
2026-06-09 Officer/Director Change View
2026-06-02 Other Events; Exhibits View
2026-06-01 Regulation FD; Other Events; Exhibits View
2026-05-27 Material Agreement; Financial Obligation; Exhibits Agreement View
2026-05-20 Shareholder Vote View
2026-05-07 Earnings Release; Regulation FD; Exhibits View
2026-04-30 Officer/Director Change; Exhibits View
2026-03-27 Regulation FD; Exhibits View
2026-03-17 Other Events View
2026-02-26 Results of Operations and Financial Condition; Costs Associated with Exit or Disposal Activities; Re View
2026-01-23 Departure/Election of Directors; Appointment of Officers View
2026-01-08 Results of Operations and Financial Condition; Departure/Election of Directors; Appointment of Offic View
2025-12-09 Entry into Material Definitive Agreement; Regulation FD Disclosure; Other Events; Financial Statemen Agreement View
2025-11-06 Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex View
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms